Biomiga

Biomiga is a privately-held, revenue-generating biotechnology company operating as a provider of research tools, diagnostic components, and contract services. It has established a strong position in the life sciences research supply market with its proprietary MgPure line of magnetic bead-based DNA/RNA extraction kits and related consumables, which are manufactured in the USA and offered at competitive price points. The company leverages its ISO 9001:2015 certified and FDA-registered facility to serve academic, clinical, and industrial labs, emphasizing product development, customization (OEM), and supply chain stability. While not a traditional therapeutic developer, its activities in diagnostics (PCR detection panels) and support for cell therapy workflows place it in adjacent high-growth sectors.

Magnetic bead-based nucleic acid extraction and purification (MgPure platform); Real-Time PCR assay development; Custom gene synthesis, cell line, and lentivirus services.

Biomiga competes in the life sciences research tools market against giants like Thermo Fisher Scientific, Qiagen, and Bio-Rad. Its strategy is to differentiate on price, performance (yield), customer service, and U.S.-based manufacturing stability. In the diagnostic components space, it faces competition from dedicated assay manufacturers and large diagnostic firms.